- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-octamer
- Ligands
- 16 x NAG- NAG- FUL: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Non-functional Binders)
- 16 x K: POTASSIUM ION(Non-covalent)
K.3: 2 residues within 4Å:- Chain A: Y.418, R.513
Ligand excluded by PLIPK.11: 3 residues within 4Å:- Chain A: F.523
- Chain D: F.523
- Ligands: K.62
Ligand excluded by PLIPK.20: 2 residues within 4Å:- Chain B: Y.418, R.513
Ligand excluded by PLIPK.28: 3 residues within 4Å:- Chain B: F.523
- Chain C: F.523
- Ligands: K.45
Ligand excluded by PLIPK.37: 2 residues within 4Å:- Chain C: Y.418, R.513
Ligand excluded by PLIPK.45: 3 residues within 4Å:- Chain B: F.523
- Chain C: F.523
- Ligands: K.28
Ligand excluded by PLIPK.54: 2 residues within 4Å:- Chain D: Y.418, R.513
Ligand excluded by PLIPK.62: 3 residues within 4Å:- Chain A: F.523
- Chain D: F.523
- Ligands: K.11
Ligand excluded by PLIPK.71: 2 residues within 4Å:- Chain E: Y.418, R.513
Ligand excluded by PLIPK.79: 3 residues within 4Å:- Chain E: F.523
- Chain H: F.523
- Ligands: K.130
Ligand excluded by PLIPK.88: 2 residues within 4Å:- Chain F: Y.418, R.513
Ligand excluded by PLIPK.96: 3 residues within 4Å:- Chain F: F.523
- Chain G: F.523
- Ligands: K.113
Ligand excluded by PLIPK.105: 2 residues within 4Å:- Chain G: Y.418, R.513
Ligand excluded by PLIPK.113: 3 residues within 4Å:- Chain F: F.523
- Chain G: F.523
- Ligands: K.96
Ligand excluded by PLIPK.122: 2 residues within 4Å:- Chain H: Y.418, R.513
Ligand excluded by PLIPK.130: 3 residues within 4Å:- Chain E: F.523
- Chain H: F.523
- Ligands: K.79
Ligand excluded by PLIP- 16 x SO4: SULFATE ION(Non-functional Binders)
SO4.4: 4 residues within 4Å:- Chain A: L.512, R.513, Q.516
- Chain G: R.507
Ligand excluded by PLIPSO4.12: 6 residues within 4Å:- Chain A: F.519, F.523
- Chain D: S.522, F.523, K.526
- Ligands: SO4.63
Ligand excluded by PLIPSO4.21: 4 residues within 4Å:- Chain B: L.512, R.513, Q.516
- Chain F: R.507
Ligand excluded by PLIPSO4.29: 6 residues within 4Å:- Chain B: F.519, F.523
- Chain C: S.522, F.523, K.526
- Ligands: SO4.46
Ligand excluded by PLIPSO4.38: 4 residues within 4Å:- Chain C: L.512, R.513, Q.516
- Chain H: R.507
Ligand excluded by PLIPSO4.46: 6 residues within 4Å:- Chain B: S.522, F.523, K.526
- Chain C: F.519, F.523
- Ligands: SO4.29
Ligand excluded by PLIPSO4.55: 4 residues within 4Å:- Chain D: L.512, R.513, Q.516
- Chain E: R.507
Ligand excluded by PLIPSO4.63: 6 residues within 4Å:- Chain A: S.522, F.523, K.526
- Chain D: F.519, F.523
- Ligands: SO4.12
Ligand excluded by PLIPSO4.72: 4 residues within 4Å:- Chain D: R.507
- Chain E: L.512, R.513, Q.516
Ligand excluded by PLIPSO4.80: 6 residues within 4Å:- Chain E: F.519, F.523
- Chain H: S.522, F.523, K.526
- Ligands: SO4.131
Ligand excluded by PLIPSO4.89: 4 residues within 4Å:- Chain B: R.507
- Chain F: L.512, R.513, Q.516
Ligand excluded by PLIPSO4.97: 6 residues within 4Å:- Chain F: F.519, F.523
- Chain G: S.522, F.523, K.526
- Ligands: SO4.114
Ligand excluded by PLIPSO4.106: 4 residues within 4Å:- Chain A: R.507
- Chain G: L.512, R.513, Q.516
Ligand excluded by PLIPSO4.114: 6 residues within 4Å:- Chain F: S.522, F.523, K.526
- Chain G: F.519, F.523
- Ligands: SO4.97
Ligand excluded by PLIPSO4.123: 4 residues within 4Å:- Chain C: R.507
- Chain H: L.512, R.513, Q.516
Ligand excluded by PLIPSO4.131: 6 residues within 4Å:- Chain E: S.522, F.523, K.526
- Chain H: F.519, F.523
- Ligands: SO4.80
Ligand excluded by PLIP- 24 x GOL: GLYCEROL(Non-functional Binders)
GOL.5: 2 residues within 4Å:- Chain A: K.43
- Chain E: K.103
Ligand excluded by PLIPGOL.6: 5 residues within 4Å:- Chain A: L.16, Y.59, W.96, D.127, K.129
Ligand excluded by PLIPGOL.13: 7 residues within 4Å:- Chain A: W.229, T.232, E.236, R.240, L.284, S.285, V.286
Ligand excluded by PLIPGOL.22: 2 residues within 4Å:- Chain B: K.43
- Chain H: K.103
Ligand excluded by PLIPGOL.23: 5 residues within 4Å:- Chain B: L.16, Y.59, W.96, D.127, K.129
Ligand excluded by PLIPGOL.30: 7 residues within 4Å:- Chain B: W.229, T.232, E.236, R.240, L.284, S.285, V.286
Ligand excluded by PLIPGOL.39: 2 residues within 4Å:- Chain C: K.43
- Chain F: K.103
Ligand excluded by PLIPGOL.40: 5 residues within 4Å:- Chain C: L.16, Y.59, W.96, D.127, K.129
Ligand excluded by PLIPGOL.47: 7 residues within 4Å:- Chain C: W.229, T.232, E.236, R.240, L.284, S.285, V.286
Ligand excluded by PLIPGOL.56: 2 residues within 4Å:- Chain D: K.43
- Chain G: K.103
Ligand excluded by PLIPGOL.57: 5 residues within 4Å:- Chain D: L.16, Y.59, W.96, D.127, K.129
Ligand excluded by PLIPGOL.64: 7 residues within 4Å:- Chain D: W.229, T.232, E.236, R.240, L.284, S.285, V.286
Ligand excluded by PLIPGOL.73: 2 residues within 4Å:- Chain C: K.103
- Chain E: K.43
Ligand excluded by PLIPGOL.74: 5 residues within 4Å:- Chain E: L.16, Y.59, W.96, D.127, K.129
Ligand excluded by PLIPGOL.81: 7 residues within 4Å:- Chain E: W.229, T.232, E.236, R.240, L.284, S.285, V.286
Ligand excluded by PLIPGOL.90: 2 residues within 4Å:- Chain A: K.103
- Chain F: K.43
Ligand excluded by PLIPGOL.91: 5 residues within 4Å:- Chain F: L.16, Y.59, W.96, D.127, K.129
Ligand excluded by PLIPGOL.98: 7 residues within 4Å:- Chain F: W.229, T.232, E.236, R.240, L.284, S.285, V.286
Ligand excluded by PLIPGOL.107: 2 residues within 4Å:- Chain B: K.103
- Chain G: K.43
Ligand excluded by PLIPGOL.108: 5 residues within 4Å:- Chain G: L.16, Y.59, W.96, D.127, K.129
Ligand excluded by PLIPGOL.115: 7 residues within 4Å:- Chain G: W.229, T.232, E.236, R.240, L.284, S.285, V.286
Ligand excluded by PLIPGOL.124: 2 residues within 4Å:- Chain D: K.103
- Chain H: K.43
Ligand excluded by PLIPGOL.125: 5 residues within 4Å:- Chain H: L.16, Y.59, W.96, D.127, K.129
Ligand excluded by PLIPGOL.132: 7 residues within 4Å:- Chain H: W.229, T.232, E.236, R.240, L.284, S.285, V.286
Ligand excluded by PLIP- 24 x CL: CHLORIDE ION(Non-functional Binders)
CL.7: 3 residues within 4Å:- Chain A: Q.314, N.412, N.413
Ligand excluded by PLIPCL.9: 1 residues within 4Å:- Chain A: R.345
Ligand excluded by PLIPCL.10: 1 residues within 4Å:- Chain A: T.510
Ligand excluded by PLIPCL.24: 3 residues within 4Å:- Chain B: Q.314, N.412, N.413
Ligand excluded by PLIPCL.26: 1 residues within 4Å:- Chain B: R.345
Ligand excluded by PLIPCL.27: 1 residues within 4Å:- Chain B: T.510
Ligand excluded by PLIPCL.41: 3 residues within 4Å:- Chain C: Q.314, N.412, N.413
Ligand excluded by PLIPCL.43: 1 residues within 4Å:- Chain C: R.345
Ligand excluded by PLIPCL.44: 1 residues within 4Å:- Chain C: T.510
Ligand excluded by PLIPCL.58: 3 residues within 4Å:- Chain D: Q.314, N.412, N.413
Ligand excluded by PLIPCL.60: 1 residues within 4Å:- Chain D: R.345
Ligand excluded by PLIPCL.61: 1 residues within 4Å:- Chain D: T.510
Ligand excluded by PLIPCL.75: 3 residues within 4Å:- Chain E: Q.314, N.412, N.413
Ligand excluded by PLIPCL.77: 1 residues within 4Å:- Chain E: R.345
Ligand excluded by PLIPCL.78: 1 residues within 4Å:- Chain E: T.510
Ligand excluded by PLIPCL.92: 3 residues within 4Å:- Chain F: Q.314, N.412, N.413
Ligand excluded by PLIPCL.94: 1 residues within 4Å:- Chain F: R.345
Ligand excluded by PLIPCL.95: 1 residues within 4Å:- Chain F: T.510
Ligand excluded by PLIPCL.109: 3 residues within 4Å:- Chain G: Q.314, N.412, N.413
Ligand excluded by PLIPCL.111: 1 residues within 4Å:- Chain G: R.345
Ligand excluded by PLIPCL.112: 1 residues within 4Å:- Chain G: T.510
Ligand excluded by PLIPCL.126: 3 residues within 4Å:- Chain H: Q.314, N.412, N.413
Ligand excluded by PLIPCL.128: 1 residues within 4Å:- Chain H: R.345
Ligand excluded by PLIPCL.129: 1 residues within 4Å:- Chain H: T.510
Ligand excluded by PLIP- 8 x FP1: N-hydroxy-1-(1-methylpyridin-2(1H)-ylidene)methanamine(Non-covalent)
FP1.8: 8 residues within 4Å:- Chain A: W.80, G.113, G.114, E.195, X.196, A.326, H.436, Y.438
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:H.436
- pi-Stacking: A:W.80
FP1.25: 8 residues within 4Å:- Chain B: W.80, G.113, G.114, E.195, X.196, A.326, H.436, Y.438
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:H.436
- pi-Stacking: B:W.80
FP1.42: 8 residues within 4Å:- Chain C: W.80, G.113, G.114, E.195, X.196, A.326, H.436, Y.438
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:H.436
- pi-Stacking: C:W.80
FP1.59: 8 residues within 4Å:- Chain D: W.80, G.113, G.114, E.195, X.196, A.326, H.436, Y.438
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:H.436
- pi-Stacking: D:W.80
FP1.76: 8 residues within 4Å:- Chain E: W.80, G.113, G.114, E.195, X.196, A.326, H.436, Y.438
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:H.436
- pi-Stacking: E:W.80
FP1.93: 8 residues within 4Å:- Chain F: W.80, G.113, G.114, E.195, X.196, A.326, H.436, Y.438
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:H.436
- pi-Stacking: F:W.80
FP1.110: 8 residues within 4Å:- Chain G: W.80, G.113, G.114, E.195, X.196, A.326, H.436, Y.438
2 PLIP interactions:2 interactions with chain G- Hydrogen bonds: G:H.436
- pi-Stacking: G:W.80
FP1.127: 8 residues within 4Å:- Chain H: W.80, G.113, G.114, E.195, X.196, A.326, H.436, Y.438
2 PLIP interactions:2 interactions with chain H- Hydrogen bonds: H:H.436
- pi-Stacking: H:W.80
- 32 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.14: 3 residues within 4Å:- Chain A: N.104, N.186, K.188
Ligand excluded by PLIPNAG.15: 2 residues within 4Å:- Chain A: R.12, N.55
Ligand excluded by PLIPNAG.16: 4 residues within 4Å:- Chain A: R.463, K.467, E.480, N.483
Ligand excluded by PLIPNAG.17: 1 residues within 4Å:- Chain A: N.254
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain B: N.104, N.186, K.188
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain B: R.12, N.55
Ligand excluded by PLIPNAG.33: 4 residues within 4Å:- Chain B: R.463, K.467, E.480, N.483
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain B: N.254
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain C: N.104, N.186, K.188
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain C: R.12, N.55
Ligand excluded by PLIPNAG.50: 4 residues within 4Å:- Chain C: R.463, K.467, E.480, N.483
Ligand excluded by PLIPNAG.51: 1 residues within 4Å:- Chain C: N.254
Ligand excluded by PLIPNAG.65: 3 residues within 4Å:- Chain D: N.104, N.186, K.188
Ligand excluded by PLIPNAG.66: 2 residues within 4Å:- Chain D: R.12, N.55
Ligand excluded by PLIPNAG.67: 4 residues within 4Å:- Chain D: R.463, K.467, E.480, N.483
Ligand excluded by PLIPNAG.68: 1 residues within 4Å:- Chain D: N.254
Ligand excluded by PLIPNAG.82: 3 residues within 4Å:- Chain E: N.104, N.186, K.188
Ligand excluded by PLIPNAG.83: 2 residues within 4Å:- Chain E: R.12, N.55
Ligand excluded by PLIPNAG.84: 4 residues within 4Å:- Chain E: R.463, K.467, E.480, N.483
Ligand excluded by PLIPNAG.85: 1 residues within 4Å:- Chain E: N.254
Ligand excluded by PLIPNAG.99: 3 residues within 4Å:- Chain F: N.104, N.186, K.188
Ligand excluded by PLIPNAG.100: 2 residues within 4Å:- Chain F: R.12, N.55
Ligand excluded by PLIPNAG.101: 4 residues within 4Å:- Chain F: R.463, K.467, E.480, N.483
Ligand excluded by PLIPNAG.102: 1 residues within 4Å:- Chain F: N.254
Ligand excluded by PLIPNAG.116: 3 residues within 4Å:- Chain G: N.104, N.186, K.188
Ligand excluded by PLIPNAG.117: 2 residues within 4Å:- Chain G: R.12, N.55
Ligand excluded by PLIPNAG.118: 4 residues within 4Å:- Chain G: R.463, K.467, E.480, N.483
Ligand excluded by PLIPNAG.119: 1 residues within 4Å:- Chain G: N.254
Ligand excluded by PLIPNAG.133: 3 residues within 4Å:- Chain H: N.104, N.186, K.188
Ligand excluded by PLIPNAG.134: 2 residues within 4Å:- Chain H: R.12, N.55
Ligand excluded by PLIPNAG.135: 4 residues within 4Å:- Chain H: R.463, K.467, E.480, N.483
Ligand excluded by PLIPNAG.136: 1 residues within 4Å:- Chain H: N.254
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wandhammer, M. et al., A Step Toward the Reactivation of Aged Cholinesterases -Crystal Structure of Ligands Binding to Aged Human Butyrylcholinesterase. Chem.Biol.Interact (2013)
- Release Date
- 2012-08-29
- Peptides
- CHOLINESTERASE: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-octamer
- Ligands
- 16 x NAG- NAG- FUL: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Non-functional Binders)
- 16 x K: POTASSIUM ION(Non-covalent)
- 16 x SO4: SULFATE ION(Non-functional Binders)
- 24 x GOL: GLYCEROL(Non-functional Binders)
- 24 x CL: CHLORIDE ION(Non-functional Binders)
- 8 x FP1: N-hydroxy-1-(1-methylpyridin-2(1H)-ylidene)methanamine(Non-covalent)
- 32 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wandhammer, M. et al., A Step Toward the Reactivation of Aged Cholinesterases -Crystal Structure of Ligands Binding to Aged Human Butyrylcholinesterase. Chem.Biol.Interact (2013)
- Release Date
- 2012-08-29
- Peptides
- CHOLINESTERASE: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
A